quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
of the ebola virus	99
ebola virus disease in	81
the ebola virus glycoprotein	76
republic of the congo	65
democratic republic of the	64
ebola and marburg viruses	61
severe acute respiratory syndrome	59
of ebola virus disease	57
middle east respiratory syndrome	56
of ebola hemorrhagic fever	52
in the absence of	52
east respiratory syndrome coronavirus	48
in the presence of	45
of ebola virus infection	45
the democratic republic of	37
ebola virus infection in	37
as well as the	35
for the treatment of	34
in the context of	34
of ebola and marburg	34
in the democratic republic	31
acute respiratory syndrome coronavirus	29
on the cell surface	28
human immunodeficiency virus type	28
treatment of ebola virus	27
ebola hemorrhagic fever in	27
in the case of	26
in vitro and in	26
vitro and in vivo	24
with ebola virus disease	23
recombinant vesicular stomatitis virus	23
against ebola virus infection	22
for ebola virus infection	22
patients with ebola virus	22
have been shown to	22
on the surface of	21
virus disease in guinea	21
in the united states	21
democratic republic of congo	21
been shown to be	20
has been shown to	20
of type i ifn	20
ebola virus entry requires	20
of severe acute respiratory	20
on the other hand	20
of ebola virus glycoprotein	20
of ebola virus in	20
ebola virus glycoprotein is	20
virus entry requires the	20
cells were transfected with	20
a wide range of	19
against lethal ebola virus	19
one of the most	19
in vero e cells	19
centers for disease control	18
for the detection of	18
ebola and marburg virus	18
colored fruit bat cells	18
to the plasma membrane	18
analysis of ebola virus	18
marburg and ebola viruses	18
structure of the ebola	17
of marburg hemorrhagic fever	17
for disease control and	17
proteolysis of the ebola	17
of middle east respiratory	17
essential for ebola virus	17
disease control and prevention	17
ebov gp pseudotyped hiv	17
an important role in	17
min at room temperature	16
c is essential for	16
pathogenesis of ebola hemorrhagic	16
pick c is essential	16
lethal ebola virus infection	16
the cholesterol transporter niemann	16
is essential for ebola	16
processing of the ebola	16
for ebola virus disease	16
from a human survivor	15
of ebov gp pseudotyped	15
requires the cholesterol transporter	15
type i ifn signaling	15
entry requires the cholesterol	15
by the ebola virus	15
play a role in	15
of ebola virus vp	15
during the course of	15
lethal ebola virus challenge	14
vaccine protects nonhuman primates	14
protects nonhuman primates against	14
safety and immunogenicity of	14
the ebola virus vp	14
in the treatment of	14
protection against ebola virus	14
of ebov and marv	14
of zaire ebola virus	14
ebola virus vp protein	14
a u a u	14
small molecule inhibitors reveal	14
the course of the	14
molecule inhibitors reveal niemann	14
for min at room	14
it is possible that	14
ebola virus infection with	14
the presence of the	14
t cells were seeded	14
to ebov gp cl	13
added to each well	13
emergence of zaire ebola	13
after the onset of	13
equine antisera and f	13
on the plasma membrane	13
to the cell surface	13
the extent of fusion	13
of ebola virus entry	13
fever in cynomolgus macaques	13
cells were treated with	13
gp on the cell	13
zaire ebola virus disease	13
ebola and marburg hemorrhagic	13
during the west african	13
hemorrhagic fever in cynomolgus	13
the ebov gp pseudotyped	12
a case fatality rate	12
is necessary for infection	12
it is likely that	12
a single amino acid	12
in a mouse model	12
virus disease in west	12
of the ebov gp	12
play an important role	12
glycoprotein is necessary for	12
virus glycoprotein by the	12
outbreak in west africa	12
of patients with ebola	12
virus glycoprotein is necessary	12
ebov gp on the	12
the world health organization	12
ebola haemorrhagic fever in	12
fusion of the viral	12
ebola virus glycoprotein by	12
and marburg hemorrhagic fever	12
transmission of ebola virus	12
highly pathogenic avian influenza	12
the west african outbreak	12
in the development of	12
is one of the	12
endosomal proteolysis of the	12
ebov gp pseudotyped vsv	12
venezuelan equine encephalitis virus	12
it is important to	12
a broad range of	11
compendium of years of	11
case fatality rate of	11
can be used to	11
entry mediated by the	11
a lethal dose of	11
for the development of	11
ebola virus infection is	11
proteolytic processing of the	11
of years of epidemiological	11
at the plasma membrane	11
is associated with an	11
increasing or decreasing trend	11
a compendium of years	11
the role of the	11
for h at room	11
in the present study	11
a single dose of	11
national institutes of health	11
of ebola virus and	11
h at room temperature	11
compared with pbs group	11
of human immunodeficiency virus	11
bind to ebov gp	11
cells were infected with	11
of ebola virus is	11
virion glycoproteins of ebola	11
disease in west africa	11
infection is associated with	11
by ebola and marburg	11
work was supported by	10
on the basis of	10
pick c small molecule	10
virus glycoprotein bound to	10
c small molecule inhibitors	10
glycoprotein bound to an	10
and marburg virus infections	10
to an antibody from	10
the viral life cycle	10
the antiviral activity of	10
rift valley fever virus	10
cell immunoglobulin and mucin	10
an antibody from a	10
virus disease in the	10
the host immune response	10
of the ebov genome	10
the type i interferon	10
early and sustained targets	10
in the current study	10
over the course of	10
were found to be	10
african green monkey kidney	10
vero e cells were	10
vp is essential for	10
ebola virus glycoprotein bound	10
bound to an antibody	10
persistence of ebola virus	10
was added to the	10
for the first time	10
as seen in figure	10
ebola virus entry by	10
of the viral envelope	10
virus infection is associated	10
antibody from a human	10
of advanced ebola virus	10
food and drug administration	10
of vesicular stomatitis virus	10
outbreak of ebola virus	10
immunoglobulin and mucin domain	10
cellular entry by ebola	10
gp of ebola virus	9
diagnosis of ebola hemorrhagic	9
from the cell surface	9
into the host cell	9
cathepsins b and l	9
role of type i	9
not required for ebola	9
of marburg virus disease	9
infection and vlp entry	9
vero e and huh	9
required for ebola virus	9
elucidates ebola virus origin	9
trvlp infection and vlp	9
with massive lymphocyte apoptosis	9
the structure of the	9
it is conceivable that	9
first months of the	9
in the exporting country	9
in the plasma membrane	9
antibodies against ebola virus	9
virus infection ebola virus	9
genomic surveillance elucidates ebola	9
treatment of ebola hemorrhagic	9
of the epidemic and	9
the united states and	9
of the type i	9
of the ifn system	9
these results suggest that	9
it should be noted	9
associated with an aberrant	9
an aberrant innate immunity	9
infected with ebola virus	9
this work was supported	9
of proinflammatory cytokines and	9
cells were seeded in	9
are early and sustained	9
at h post transfection	9
e and huh cells	9
surveillance elucidates ebola virus	9
origin and transmission during	9
are not required for	9
peripheral blood mononuclear cells	9
a large number of	9
immunity and with massive	9
analysis and interpretation of	9
at the time of	9
cleavage of ebov gp	9
and sustained targets of	9
at an moi of	9
and interpretation of data	9
transmission during the outbreak	9
aberrant innate immunity and	9
virus origin and transmission	9
ebola virus origin and	9
and with massive lymphocyte	9
with fetal bovine serum	9
infection ebola virus entry	9
and vesicular stomatitis virus	9
proportion of the year	9
and transmission during the	9
months of the epidemic	9
liberia and sierra leone	9
ebola virus infection by	9
to bind to ebov	9
the absence of other	9
the inoculum was removed	9
effector and target cells	9
innate immunity and with	9
with an aberrant innate	9
a high degree of	9
luciferase reporter gene inhibition	8
the human ebov infection	8
reservoirs of ebola virus	8
this study was to	8
of marburg virus and	8
in the pathogenesis of	8
contact with bodily fluids	8
ebola virus can be	8
on vero e cells	8
fruit bats as reservoirs	8
the total number of	8
the plasma membrane and	8
like particles produced in	8
as a result of	8
of the immune system	8
a final concentration of	8
that dendritic cells are	8
the end of the	8
we found that a	8
nonhuman primates against ebola	8
human fatal zaire ebola	8
is not required for	8
outbreaks of ebola virus	8
protect nonhuman primates against	8
at the level of	8
reporter gene inhibition assay	8
the spike protein of	8
it has been shown	8
from discovery to vaccine	8
incubated for h at	8
and the cells were	8
dendritic cells are early	8
infection of rhesus macaques	8
the causative agent of	8
factor viia tissue factor	8
nematode anticoagulant protein c	8
pathology of experimental ebola	8
replication of the ebov	8
the treatment of ebov	8
disease in the united	8
a member of the	8
the host cell cytoplasm	8
ebov entry and infection	8
mutation of the gxxxg	8
with a lethal dose	8
recombinant nematode anticoagulant protein	8
particles produced in insect	8
cells are early and	8
for the production of	8
the transcription and replication	8
cis and in trans	8
of marburg and ebola	8
produced in insect cells	8
in humans and nonhuman	8
the surface of the	8
of the ebov infection	8
in patients with ebola	8
rapid diagnosis of ebola	8
the size of the	8
against ebola and marburg	8
fatal zaire ebola virus	8
the probability of introduction	8
zaire ebola virus infection	8
was found to be	8
the epidemic and forward	8
used in this study	8
of the gxxxg motif	8
cells by macropinocytosis and	8
the authors declare no	8
should be noted that	8
sustained targets of infection	8
evidence that dendritic cells	8
outbreak in the democratic	8
to ebola virus glycoprotein	8
a u and a	8
scientific and technical committee	8
the human immunodeficiency virus	8
has been detected in	8
bats as reservoirs of	8
at least in part	8
balb c mice were	8
acute respiratory distress syndrome	8
antibodies to ebola virus	8
in the endoplasmic reticulum	8
for the identification of	8
epidemic and forward projections	8
haemorrhagic fever in zaire	8
of experimental ebola virus	8
in cis and in	8
protection from ebola virus	8
in addition to the	8
of the marburg virus	8
transcription and replication of	8
in the mouse model	8
to a lesser extent	8
to the development of	8
of this study was	8
to that of the	8
generation of therapeutic antisera	8
of personal protective equipment	8
for h at rt	8
in an outbreak setting	8
by marburg and ebola	8
as reservoirs of ebola	8
mediated by the ebola	8
selective estrogen receptor modulators	8
the average number of	8
against a lethal challenge	8
international scientific and technical	8
entry of ebola virus	8
mediate cellular entry by	7
by using pseudotyped viruses	7
in the formation of	7
glycoproteins of ebola viruses	7
t cells were transfected	7
inoculum was removed and	7
outbreak setting and assessment	7
a role in the	7
mpxv infection resulted in	7
zaire ebolavirus and lake	7
ebola viruses are encoded	7
among the three areas	7
against a lethal ebola	7
the receptor binding domain	7
nonhuman primates from filovirus	7
ebov gp is cleaved	7
of type i ifns	7
ebola hemorrhagic fever by	7
a small animal model	7
setting and assessment of	7
for the determination of	7
cathepsins in entry mediated	7
probability of introduction for	7
of the ebov in	7
from egyptian fruit bats	7
the ebola virus disease	7
the recent outbreak of	7
virus entry by using	7
innate and adaptive immune	7
are expressed through transcriptional	7
epidemic in western africa	7
course of the experiment	7
frames and are expressed	7
advanced ebola virus disease	7
pcr in an outbreak	7
humans and nonhuman primates	7
viruses from egyptian fruit	7
g for min at	7
of ebola virus from	7
neutral with regard to	7
virus infection with a	7
and a u a	7
live ebov neutralisation assay	7
of patient viral load	7
cd and cd t	7
nature remains neutral with	7
by ebola virus in	7
published maps and institutional	7
protects nonhuman primates from	7
similar to that of	7
role of endosomal cathepsins	7
virus in cis and	7
could be due to	7
the virion glycoproteins of	7
of endosomal cathepsins in	7
proinflammatory cytokines and chemokines	7
a lethal ebola virus	7
macrophages and dendritic cells	7
to jurisdictional claims in	7
are encoded in two	7
prophylaxis protects nonhuman primates	7
host cells by macropinocytosis	7
characterization of ebola virus	7
based on these data	7
enters host cells by	7
as a predictor of	7
and lake victoria marburgvirus	7
virus and marburg virus	7
viruses are encoded in	7
at the cell surface	7
springer nature remains neutral	7
of ebola viruses are	7
antibody prophylaxis protects nonhuman	7
remains neutral with regard	7
in entry mediated by	7
medium was replaced by	7
entry by using pseudotyped	7
an outbreak setting and	7
disease in nonhuman primates	7
were observed in the	7
at a concentration of	7
crystal structure of the	7
with regard to jurisdictional	7
ebolavirus and lake victoria	7
three viral data sets	7
against ebola virus in	7
jurisdictional claims in published	7
claims in published maps	7
was shown to be	7
inhibit ebola virus infection	7
these results demonstrate that	7
institute of infectious diseases	7
type i interferon response	7
was used for the	7
a receptor for zaire	7
or revising the article	7
single amino acid change	7
mice and guinea pigs	7
ebola virus in cis	7
primates from filovirus disease	7
and supplementary figure s	7
protection against lethal challenge	7
entry of the ebov	7
maps and institutional affiliations	7
two reading frames and	7
is safe and immunogenic	7
assessment of patient viral	7
during the recovery process	7
virus disease in nonhuman	7
in the form of	7
can be used as	7
receptor for zaire ebolavirus	7
patient viral load as	7
the onset of symptoms	7
the early stages of	7
in two reading frames	7
and functional characterization of	7
the ability of the	7
drafting or revising the	7
recombinant inhibitor of factor	7
hek t cells were	7
load as a predictor	7
initial viral load on	7
diverse marburg viruses from	7
of the family filoviridae	7
a lethal ebov challenge	7
of ebola virus during	7
has not yet been	7
recombinant human activated protein	7
a mouse model of	7
viral load as a	7
the ebov infection in	7
species of ebola virus	7
as a surrogate for	7
the centers for disease	7
ebola virus enters host	7
ebola virus and marburg	7
in published maps and	7
endosomal cathepsins in entry	7
supplemented with fetal bovine	7
may not be a	7
safe and immunogenic in	7
of gp and gp	7
enhancement of ebola virus	7
of influenza a virus	7
the us department of	7
and are expressed through	7
fever by reverse transcription	7
for ebola virus replication	7
have been associated with	7
regard to jurisdictional claims	7
and tumor necrosis factor	7
and assessment of patient	7
the vesicular stomatitis virus	7
responses in ebola virus	7
during the outbreak in	7
remains to be determined	7
expressed through transcriptional editing	7
have been detected in	7
were obtained from the	7
marburg viruses from egyptian	7
encoded in two reading	7
reading frames and are	7
the matrix protein vp	7
a predictor of outcome	7
virus entry and infection	7
a critical role in	7
the first months of	7
in the respiratory tract	7
and replication of the	7
binding in the presence	7
isolation of genetically diverse	7
influenza a h n	7
fecal samples were collected	7
both ebov and marv	7
hemorrhagic fever by reverse	7
sign mediate cellular entry	7
genetically diverse marburg viruses	7
as a function of	7
sequence analysis of the	7
activity against ebola virus	7
virus and ebola virus	7
infection in rhesus macaques	7
for zaire ebolavirus and	7
of host immune responses	7
of genetically diverse marburg	7
entry by ebola virus	7
virus enters host cells	7
postexposure antibody prophylaxis protects	7
human activated protein c	7
is a receptor for	7
ebola virus disease outbreak	7
the west african ebola	7
ge healthcare life sciences	6
was based on the	6
of the envelope glycoprotein	6
successful treatment of ebola	6
employ different strategies to	6
therapy prolongs survival in	6
by antibody produced in	6
in ebov infected mice	6
there is no evidence	6
the gp of the	6
inhibitor of factor viia	6
on the raw product	6
was associated with a	6
macrophages and endothelial cells	6
is not essential for	6
prolongs survival in rhesus	6
covalent modifications of the	6
of ebola virus nucleocapsid	6
not included in the	6
an average weight loss	6
transfusions from convalescent patients	6
the ebola virus polymerase	6
of the ebov trailer	6
functional analysis of ebola	6
reversion of advanced ebola	6
polymerase and by t	6
disease in sierra leone	6
therapeutic antisera for emerging	6
congo hemorrhagic fever virus	6
the base of the	6
host cells via macropinocytosis	6
role of vp in	6
modifications of the ebola	6
are thought to be	6
ebola virus is edited	6
cells were grown in	6
the proprotein convertase furin	6
infection by a potently	6
of the west african	6
virus glycoprotein is not	6
have been used in	6
to ebola and marburg	6
lectin specific for galactose	6
eye and male reproductive	6
t and vaccinia virus	6
with a recombinant inhibitor	6
a vesicular stomatitis virus	6
the inhibition of the	6
boosted and weeks later	6
risk of human infection	6
i ifn signaling in	6
respiratory syndrome coronavirus infection	6
gp mrna of ebola	6
of ebov and other	6
direct effect of virus	6
glycoproteins of marburg and	6
the envelope glycoprotein gp	6
seasonal pulses of marburg	6
phase i clinical trial	6
by a potently neutralizing	6
is assumed to be	6
as described in the	6
has been shown that	6
the rule of six	6
human asymptomatic ebola infection	6
and boosted and weeks	6
cells were maintained in	6
structure of the ebov	6
with blood transfusions from	6
during the recent outbreak	6
has been used to	6
in rhesus macaque models	6
gxxxg motif in the	6
time to clinical signs	6
macaque models of ebola	6
ebola hemorrhagic fever with	6
dronedarone and verapamil inhibit	6
of a number of	6
glycoprotein by the proprotein	6
the treatment was given	6
average weight loss of	6
virus disease in sierra	6
infection prevention and control	6
cd t cell responses	6
the ratio of the	6
marburg virus circulation in	6
for host cell entry	6
the treatment of ebola	6
after the first immunization	6
infection and strong inflammatory	6
in contrast to the	6
studies have demonstrated that	6
for the presence of	6
at a dilution of	6
into host cells via	6
induced cytolysis of endothelial	6
for marburg hemorrhagic fever	6
replication in cell culture	6
system for functional analysis	6
to secondary lymphoid tissues	6
of the viral genome	6
protective efficacy of neutralizing	6
the outbreak in kikwit	6
ebolavirus is internalized into	6
pathogenic avian influenza virus	6
host cell entry of	6
of the zaire ebov	6
imported case of marburg	6
the absence of any	6
case of marburg hemorrhagic	6
human ebola virus infection	6
vaccine expressing ebola virus	6
the glycan cap and	6
k akt mtor signaling	6
of npc domain c	6
inhibitors of ebola virus	6
virus infection in monkeys	6
coincide with periods of	6
edited by the ebola	6
as shown in fig	6
ebola virus envelope glycoprotein	6
fig a and b	6
no competing interests were	6
nonhuman primates with zmapp	6
in the viral envelope	6
are associated with fatal	6
glycoprotein sgp of ebola	6
use of personal protective	6
the acute phase of	6
entry into cell lines	6
type lectin specific for	6
circulation in juvenile rousettus	6
by t and vaccinia	6
we show that the	6
in nonhuman primates with	6
the length of the	6
rousettus aegyptiacus bats coincide	6
of therapeutic antisera for	6
with an average weight	6
ebola virus infection ebola	6
binding to ebola virus	6
study in rhesus monkeys	6
and male reproductive tract	6
pseudotyped virus neutralisation assays	6
macropinocytosis in a viral	6
sgp of ebola virus	6
the fact that the	6
pi k akt mtor	6
with ebola and marburg	6
dependent enhancement of ebola	6
survival in rhesus macaque	6
nonstructural small glycoprotein sgp	6
mechanism of binding to	6
threat to public health	6
nonhuman primates against infection	6
the formation of the	6
against the ebov infection	6
virus is edited by	6
cathepsin l and b	6
of the virus in	6
u and a u	6
antibody produced in natural	6
as compared to the	6
ebola virus infection of	6
is internalized into host	6
were added to each	6
a recombinant inhibitor of	6
with increasing amounts of	6
juvenile rousettus aegyptiacus bats	6
increased risk of human	6
internalized into host cells	6
with periods of increased	6
and vaccinia virus polymerases	6
during ebola virus infection	6
with the endosomal membrane	6
approved selective estrogen receptor	6
virus polymerase and by	6
glycoprotein by the zmapp	6
neutralized by antibody produced	6
the eye and male	6
are given in table	6
bats coincide with periods	6
cytolysis of endothelial cells	6
of factor viia tissue	6
as a worst case	6
receptor modulators inhibit ebola	6
have been reported to	6
rhesus macaque models of	6
protection against lethal ebola	6
protective monotherapy against lethal	6
have been found to	6
cellular entry of ebola	6
of increased risk of	6
detection of antibodies to	6
ebola virus polymerase and	6
samples were collected from	6
virus disease in humans	6
virus disease outbreak in	6
in juvenile rousettus aegyptiacus	6
has been associated with	6
fold serial dilutions of	6
fever with blood transfusions	6
growth in human cells	6
a system for functional	6
small glycoprotein sgp of	6
asymptomatic ebola infection and	6
to each well and	6
virus infection by a	6
hemorrhagic fever with blood	6
is edited by the	6
in humans and animals	6
were found in the	6
in jui government hospital	6
of marburg virus glycoprotein	6
monotherapy against lethal ebola	6
the nonstructural small glycoprotein	6
in the ebola virus	6
the s protein of	6
virus circulation in juvenile	6
blood transfusions from convalescent	6
the authors declare that	6
pick type c disease	6
terminal heptad repeat region	6
is thought to be	6
different strategies to counteract	6
pulses of marburg virus	6
and by t and	6
guinea pigs against a	6
competing interests were disclosed	6
the pathogenesis of ebola	6
ebola virus during the	6
ebola infection and strong	6
cells via macropinocytosis in	6
aegyptiacus bats coincide with	6
ebola in sierra leone	6
virus prevalence in bats	6
in natural human infection	6
regarded as sl reference	6
of binding to ebola	6
by the proprotein convertase	6
be effectively neutralized by	6
rhesus macaques infected with	6
of the immune response	6
the stability of the	6
for functional analysis of	6
protection of nonhuman primates	6
virus can be effectively	6
infection with a recombinant	6
viral transcription and replication	6
the internal fusion loop	6
the medium was removed	6
in a phase i	6
at a dose of	6
estrogen receptor modulators inhibit	6
was performed as described	6
with a case fatality	6
of three independent experiments	6
modulators inhibit ebola virus	6
of the risk of	6
effectively neutralized by antibody	6
the absence of a	6
primates against infection with	6
of ebola virus gp	6
ebola virus glycoprotein gp	6
vaccine for ebola virus	6
in humans infected with	6
produced in natural human	6
of marburg virus circulation	6
in the range of	6
a potently neutralizing antibody	6
as a positive control	6
and strong inflammatory response	6
copies of ebov gp	6
at the end of	6
viral spread in tetherin	6
a worst case scenario	6
can be effectively neutralized	6
of the human immunodeficiency	6
macaques with monoclonal antibodies	6
models of ebola and	6
cynomolgus macaques with monoclonal	6
the protective efficacy of	6
via macropinocytosis in a	6
cell entry of ebola	6
periods of increased risk	6
a study in rhesus	6
ebov gp pseudotyped virus	6
mrna of ebola virus	6
recognition of an intracellular	5
available as supplementary data	5
a small nonhuman primate	5
were washed with pbs	5
to be effective in	5
the second luminal domain	5
has been suggested that	5
to ebola virus in	5
version of this article	5
factor in primate monocytes	5
protection against the ebov	5
glycoprotein structure and mechanism	5
glycoproteins for efficient entry	5
and inhibit ebola virus	5
clinical management of ebola	5
trafficking through early and	5
primates against ebola and	5
is the use of	5
the proportion of the	5
by the addition of	5
inhibit ebola virus entry	5
to impact the course	5
and extensive intravascular apoptosis	5
a direct effect of	5
folate receptor alpha and	5
cells were washed with	5
virus binding and infectivity	5
plays an important role	5
and rift valley fever	5
of the congo and	5
of hepatitis c virus	5
region of ebov gp	5
protein of marburg virus	5
effects of ebola virus	5
clinical features of patients	5
lsectin interacts with filovirus	5
fasman beta turn prediction	5
are available from the	5
were transfected with the	5
at the same time	5
spike protein of sars	5
viraly r schmidt et	5
and a mtd of	5
the course of ebola	5
hemorrhagic fever in primate	5
is composed of a	5
the ebola virus glycoproteins	5
endothelial cell activation and	5
cells were stained with	5
clinical observations in patients	5
rvsv ebola vaccine in	5
hepatitis c virus infection	5
background level of neutralisation	5
is not a direct	5
ebola virus disease ebola	5
were infected with ebov	5
associated with fatal ebola	5
ebola virus challenge with	5
the survival of filoviruses	5
by the observation that	5
r schmidt et al	5
b and l activate	5
outbreak of marburg hemorrhagic	5
marburg virus glycoproteins for	5
vaccine in africa and	5
host immune responses in	5
used for the determination	5
mice against a lethal	5
emini surface accessibility prediction	5
humoral responses and extensive	5
the gp subunit is	5
infection of macrophages and	5
national institute of allergy	5
nonhuman primates against lethal	5
a percentage of the	5
glycoprotein gp of ebola	5
evaluated in this study	5
assays have been developed	5
a mouse model for	5
type i ifn induction	5
expressing ebola virus gp	5
small nonhuman primate model	5
mice that received vlps	5
of type i interferons	5
clomiphene and its isomers	5
a phase i clinical	5
l activate ebola but	5
extents of fusion were	5
the time to recovery	5
is a key event	5
of antibodies to ebola	5
for the selection of	5
a novel mechanism of	5
a wide variety of	5
to play an important	5
programmed recognition of an	5
and marburg viruses in	5
virus assembly and budding	5
responses and extensive intravascular	5
host for the reston	5
swine as a host	5
data at jac online	5
was used as a	5
a dose of mg	5
of filovirus entry into	5
essential data or reagents	5
at h post infection	5
transfection medium was replaced	5
dose of mg kg	5
with fatal outcome in	5
beta therapy prolongs survival	5
the activity of the	5
inhibition of ebola virus	5
of swine as a	5
the cells were washed	5
stretch of tnc mutations	5
the viral envelope with	5
recombinant vesicular stomatitis viruses	5
virus glycoproteins for efficient	5
ebola virus persistence in	5
the international committee on	5
humans infected with sudan	5
at the base of	5
phase trials of rvsv	5
how ebola and marburg	5
in the transmission of	5
as a host for	5
nonhuman primate model for	5
virus involves uptake by	5
macrophages independent of tmprss	5
available therapeutic agents that	5
determined by plaque assay	5
of the influenza virus	5
a lethal challenge of	5
a host for the	5
a luciferase reporter gene	5
clinically approved drugs amiodarone	5
filovirus glycoproteins and the	5
in ebola hemorrhagic fever	5
in patients with evd	5
was removed and the	5
primate monocytes macrophages is	5
against a lethal ebov	5
of ebola virus transmission	5
available to authorized users	5
defective humoral responses and	5
and l activate ebola	5
committee on taxonomy of	5
the binding of the	5
were collected from the	5
from bodily fluids and	5
interacts with filovirus glycoproteins	5
by interfering with the	5
in an animal model	5
caveolae are not required	5
development and evaluation of	5
the background level of	5
in this study were	5
specific for galactose and	5
recombinant vaccine protects nonhuman	5
read and approved the	5
protein of sars coronavirus	5
that they have no	5
an important step in	5
error of the mean	5
the virus in the	5
respiratory syndrome coronavirus in	5
marburg virus infection in	5
least one introduction event	5
factors that influence ebola	5
of ebov gp and	5
macrophages is a key	5
protection of guinea pigs	5
and macrophages independent of	5
wag and np i	5
authors declare that they	5
were added to the	5
immunogenic in healthy adults	5
and mechanism of entry	5
the ebola virus envelope	5
declare that they have	5
the relative importance of	5
may be able to	5
ebov gp pseudotyped viruses	5
ad vaccine expressing ebola	5
it is assumed that	5
the online version of	5
and caveolae are not	5
ebola virus mediated by	5
and subsequent trafficking through	5
the active microfluidic cartridge	5
that does not require	5
and verapamil inhibit filovirus	5
it is plausible that	5
and severe acute respiratory	5
intravascular apoptosis are associated	5
clinical illness and outcomes	5
antisera for emerging viraly	5
a neutralizing human antibody	5
likely due to the	5
in multiple cell types	5
ebola virus involves uptake	5
the protein data bank	5
up of convalescent ebola	5
of the role of	5
entry requires the host	5
infection in an animal	5
at least one introduction	5
of ebov infection in	5
antibodies in scfv format	5
be due to the	5
has the potential to	5
budding of vp virus	5
common increasing or decreasing	5
into cell lines and	5
in a viral glycoprotein	5
of the host cell	5
in the nhp model	5
screen of approved drugs	5
recombinant ad vaccine expressing	5
the antiviral factor tetherin	5
of marburg virus is	5
risk of ebola virus	5
is available to authorized	5
discovery of swine as	5
glycoproteins and the spike	5
infection results in substantial	5
for both ebov and	5
from lethal ebov infection	5
that is critical for	5
impact the course of	5
strain of marburg virus	5
the national institutes of	5
are part of the	5
are one of the	5
vp to budding of	5
of convalescent ebola hemorrhagic	5
prophylaxis of ebola virus	5
multiple cationic amphiphiles induce	5
it has been suggested	5
fails to impact the	5
course of ebola virus	5
mechanisms underlying coagulation abnormalities	5
alpha and caveolae are	5
associated with fatal outcome	5
with ebola in sierra	5
as part of the	5
mutable targets of the	5
glycoproteins of ebola virus	5
no conflict of interest	5
n and h n	5
abnormalities in ebola hemorrhagic	5
virus in sierra leone	5
of gp on the	5
efficient growth in human	5
decay in the environment	5
at the significance level	5
cells were transduced with	5
may play a role	5
enhances virus binding and	5
have an impact on	5
bodily fluids and fomites	5
members of the filoviridae	5
hemorrhagic fever in kikwit	5
to budding of vp	5
live attenuated recombinant vaccine	5
stored at room temperature	5
in the course of	5
viruses battle the immune	5
a multiplicity of infection	5
marburg viruses battle the	5
the cells were then	5
is able to inhibit	5
and immunogenic in healthy	5
both humoral and cellular	5
was dependent on the	5
evaluated in our study	5
the cathepsin b inhibitor	5
at the higher ah	5
viral rna polymerase inhibitor	5
to counteract the antiviral	5
subsequent trafficking through early	5
in africa and europe	5
of ebov infection and	5
the vp protein of	5
mechanism and subsequent trafficking	5
the majority of the	5
t cell responses to	5
pick c phenotype and	5
short stretch of tnc	5
through a sucrose cushion	5
virus structure of the	5
of rvsv ebola vaccine	5
it has been reported	5
and increased vascular permeability	5
particles from infected cells	5
and evaluation of a	5
virus gp is safe	5
genome replication and transcription	5
infected cynomolgus macaques with	5
has been isolated from	5
virus decay in the	5
of allergy and infectious	5
ebolavirus glycoprotein structure and	5
indicating that it is	5
infection in nonhuman primates	5
the mean hospitalization time	5
antiviral activities in cell	5
ebola virus glycoprotein and	5
and outcomes in patients	5
cd t cell response	5
to be required for	5
phenotype and inhibit ebola	5
entry driven by both	5
chou and fasman beta	5
in ebola virus disease	5
rna secondary structures in	5
and enhance infection of	5
cell lines and macrophages	5
structure and mechanism of	5
mean hospitalization time for	5
marburg hemorrhagic fever in	5
ebola virus infection results	5
entry of ebola and	5
a retrospective cohort study	5
with sudan ebola virus	5
of ebov gp on	5
type i ifn antagonist	5
with middle east respiratory	5
an outbreak of ebola	5
which is available to	5
of tissue factor in	5
in gabonese bat populations	5
attenuated recombinant vaccine protects	5
fatal outcome in ebola	5
had no effect on	5
primates against a lethal	5
the development of new	5
institute of allergy and	5
of filoviruses in liquids	5
ebola virus glycoprotein as	5
virus transmission from bodily	5
core structure of the	5
in response to the	5
not a direct effect	5
subunits gp and gp	5
for galactose and n	5
with fatal ebola virus	5
characterization of the ebola	5
persistence in semen of	5
culture supernatants were harvested	5
for emerging viraly r	5
the ebola virus genome	5
minimize the risk of	5
verapamil inhibit filovirus cell	5
vpu employ different strategies	5
h n and h	5
for the generation of	5
receptor alpha and caveolae	5
virus infection results in	5
tissue factor in primate	5
that influence ebola antiviral	5
enhance infection of macrophages	5
may also contribute to	5
a final volume of	5
the extents of fusion	5
specific for the viral	5
an animal model by	5
vp is involved in	5
primate model for filovirus	5
in a small animal	5
of respiratory syncytial virus	5
for ebola and marburg	5
coagulation abnormalities in ebola	5
its w a mutant	5
assessment of the risk	5
challenge with rna interference	5
from the surface of	5
lethal dose of ebov	5
that the expression of	5
of severe ebola virus	5
motif in the transmembrane	5
neutralizing antibody fails to	5
in patients with severe	5
that a fraction of	5
with filovirus glycoproteins and	5
protection against ebov infection	5
proteins vp and vp	5
the highest probability of	5
at a multiplicity of	5
no conflicts of interest	5
and cd t cells	5
sudan ebola hemorrhagic fever	5
but not marburg virus	5
viruses such as hiv	5
convalescent ebola hemorrhagic fever	5
and the spike protein	5
c phenotype and inhibit	5
entry into target cells	5
the cells were incubated	5
virus glycoproteins enhances virus	5
lifecycle in host cells	5
independent of tmprss expression	5
fatal ebola virus infection	5
the amount of cleaved	5
hemorrhage is not a	5
t cell responses are	5
postexposure prophylaxis of ebola	5
contribution of ebola virus	5
used to assess the	5
patients infected with ebov	5
kolaskar and tongaonkar antigenicity	5
bind ebola glycoproteins and	5
guinea pigs and nonhuman	5
of human peripheral blood	5
the ph dependence of	5
h n influenza virus	5
ebola virus by using	5
then added to each	5
for the viral nucleoprotein	5
of the viral rna	5
the reciprocal of the	5
antibody fails to impact	5
that hemorrhage is not	5
model by passive transfer	5
on the day of	5
ebola virus glycoproteins enhances	5
marburg virus and ebola	5
was assumed to be	5
laboratory diagnosis of ebola	5
of the filoviridae family	5
lines and macrophages independent	5
infected with sudan ebola	5
have no competing interests	5
overexpression of tissue factor	5
common among the three	5
based vaccine design against	5
plays a role in	5
that are important for	5
the molecular basis of	5
glycoproteins and enhance infection	5
influence ebola antiviral activities	5
case of ebola virus	5
of marburg virus in	5
ebola glycoproteins and enhance	5
apoptosis are associated with	5
of at least one	5
to cleave ebov gp	5
and middle east respiratory	5
survival of filoviruses in	5
samples were collected in	5
the efficacy of remdesivir	5
on taxonomy of viruses	5
ebola virus transmission from	5
of macrophages and endothelial	5
with the exception of	5
has been reported to	5
unpublished essential data or	5
involves uptake by a	5
as supplementary data at	5
and fasman beta turn	5
transfer of a neutralizing	5
underlying coagulation abnormalities in	5
standard error of the	5
of ebola virus involves	5
in primate monocytes macrophages	5
were used to infect	5
the role of this	5
in substantial immune activation	5
the hepatitis c virus	5
outcomes in patients with	5
elevated levels of interferon	5
note springer nature remains	5
management of ebola virus	5
the transfection medium was	5
the binding site for	5
for the reston ebolavirus	5
illness and outcomes in	5
which is important for	5
amphiphiles induce a niemann	5
in a variety of	5
the risk of ebola	5
and the role of	5
ebola antiviral activities in	5
functional characterization of the	5
cell fusion mediated by	5
authors declare no competing	5
in a manner that	5
and influenza a virus	5
have been developed for	5
and marburg viruses using	5
trials of rvsv ebola	5
the transmembrane domain of	5
of a neutralizing human	5
under the age of	5
is required for the	5
extensive intravascular apoptosis are	5
type calcium channel blocker	5
and marburg viruses battle	5
erk mapk and pi	5
cationic amphiphiles induce a	5
online version of this	5
due to the lack	5
been detected in the	5
has yet to be	5
vesicular stomatitis virus vectors	5
in sierra leone ebola	5
signr bind ebola glycoproteins	5
pigs and nonhuman primates	5
ebola virus entry and	5
dynamics of ebola virus	5
for efficient entry into	5
in liver and spleen	5
strategies to counteract the	5
of an intracellular receptor	5
virus glycoprotein as the	5
in the common marmoset	5
mapk and pi k	5
cells were then incubated	5
ebola virus gp is	5
animal model by passive	5
and samples were collected	5
a u u a	5
the clinically approved drugs	5
of the disease and	5
ebola virus in sierra	5
as a type i	5
due to their ability	5
outbreak in western africa	5
by ebola virus glycoprotein	5
by macropinocytosis and clathrin	5
during an outbreak of	5
evidence that hemorrhage is	5
number of years to	5
the a u mutant	5
it is clear that	5
by passive transfer of	5
for ebola virus glycoprotein	5
in a co incubator	5
inhibit filovirus cell entry	5
mediated cell entry of	5
hemorrhagic fever associated with	5
ebov infection in nhps	5
acetylgalactosamine promotes filovirus entry	5
treatment with recombinant nematode	5
humoral and cellular immunity	5
transmission from bodily fluids	5
were immunized intramuscularly with	5
to the fact that	5
and vp to budding	5
ebov lifecycle in host	5
ebov or marv gp	5
and immunogenicity of a	5
of nonhuman primates against	5
ebola but not marburg	5
ebola virus matrix protein	5
results in substantial immune	5
pigs against a lethal	5
to their ability to	5
average number of years	5
of the viral and	5
contributed unpublished essential data	5
rna viruses such as	5
the significance level of	5
supplementary data at jac	5
to the release of	5
of equine antisera and	5
twice daily for days	5
monocytes macrophages is a	5
virus challenge with rna	5
volume of pbs as	5
mediated protection against ebov	5
of ebola virus ebola	5
vp protein of ebola	5
international committee on taxonomy	5
efficient entry into cell	5
and pi k akt	5
of viral hemorrhagic fever	5
virus infection in an	5
not marburg virus glycoproteins	5
ebola virus disease patients	5
passive transfer of a	5
activate ebola but not	5
the percentage of ebov	5
gp is safe and	5
were regarded as sl	5
gorilla fecal samples were	5
marburg virus surface protein	5
fever in primate models	5
in the transmembrane domain	5
the replication of the	5
causative agent of the	5
patients with ebola in	5
markedly elevated levels of	5
have the potential to	5
glycoproteins enhances virus binding	5
emerging viraly r schmidt	5
ebola vaccine in africa	5
battle the immune system	5
detection of neutralizing antibodies	4
to nonhuman primates complete	4
the creative commons license	4
of dendritic cells and	4
undergo a subsequent fusion	4
nucleoprotein of ebola virus	4
implications for a role	4
not be sufficient to	4
from the same patient	4
internal fusion loop of	4
for inhibitors of biological	4
viruses replicate in monocyte	4
filovirus entry into vero	4
it is not clear	4
when march was expressed	4
site of ebov fusion	4
does not require tetherin	4
the lineage dual model	4
for formation of the	4
monitoring and human ebola	4
of convalescent plasma for	4
to be important for	4
and in trans dc	4
you give appropriate credit	4
a type i ifn	4
clomiphene and enclomiphene in	4
who ebola response team	4
will need to obtain	4
a significant threat to	4
cytotoxic t lymphocytes specific	4
of the year bats	4
groups of mice were	4
intended use is not	4
a standardized nomenclature for	4
of vascular cell cytotoxicity	4
ebola virus counters the	4
your intended use is	4
for replication in cell	4
virus vp protein functions	4
health and human services	4
allergy and infectious diseases	4
of bushmeat is bats	4
nonhuman primate model of	4
uniform standard error of	4
cytokines and full maturation	4
from the envelope glycoprotein	4
the virus and the	4
direct exposure to fruit	4
alpha associated with fatal	4
globulin and recombinant interferon	4
tested negative for anti	4
axl enhances macropinocytosis of	4
activation of type i	4
were infected with a	4
virus and the s	4
receptor kinase axl enhances	4
ebolavirus in humans and	4
of filoviral hemorrhagic fever	4
and neutralizing antibody responses	4
are included in the	4
united states and europe	4
a type i transmembrane	4
with one or more	4
b l are not	4
is used as a	4
clinical efficacy of remdesivir	4
was to assess the	4
lethal infection in mice	4
innate immune responses in	4
through the use of	4
in the early stages	4
assays were used to	4
ebola virus secrete mip	4
not permitted by statutory	4
against ebov infection in	4
is consistent with previous	4
for the introduction of	4
association with the lipid	4
glycan cap and the	4
these data the initial	4
figure a and b	4
require endosomal cysteine proteases	4
the role of siglec	4
of ebola virus triggers	4
and is associated with	4
pathogenesis and treatment with	4
detected in a common	4
the main viral determinant	4
viruses in gabonese bat	4
and nonfatal cases of	4
there are a number	4
cells were obtained from	4
c region of ebov	4
ebola virus infection complicated	4
infection in african straw	4
immune globulin and recombinant	4
and the evolution of	4
at the point of	4
life cycle modeling system	4
adaptation of ebov during	4
the terms and conditions	4
glycoprotein of marburg virus	4
specific cd t cells	4
absence of thermolysin treatment	4
be used as a	4
biochemical analysis of the	4
sequence and residues critical	4
study had high estimates	4
of the external solution	4
ad and protect nonhuman	4
able to inhibit the	4
of ebola virus makona	4
expression of type i	4
in the republic of	4
and weight change for	4
the specificity of the	4
was similar to that	4
immunity to ad and	4
progress in the development	4
decline of central african	4
and vero e cells	4
assumed that c min	4
stability of ebola virus	4
gp is cleaved by	4
for emerging infectious diseases	4
through early and late	4
has been reported for	4
if changes were made	4
and conditions of the	4
primates against ebola virus	4
commons license and your	4
systematic screen of fda	4
on ice for min	4
using artificial replication systems	4
a paucity of information	4
cells infected with ebola	4
and the gp subunit	4
cellular host range of	4
have a uniform standard	4
and weeks after the	4
contaminated in eu ms	4
are known to be	4
with the glycoprotein of	4
of plants and animals	4
and approved the final	4
are a number of	4
of the transcription and	4
alpha and inhibit poly	4
regulation or exceeds the	4
under a creative commons	4
cells without inducing the	4
with the lipid bilayer	4
of biological threat agents	4
years of marburg virus	4
single amino acid residue	4
the immune epitope database	4
based ebola vaccine is	4
production of cytokines and	4
cell fusion induced by	4
vesicular stomatitis virus vaccine	4
of the experiment and	4
the angola strain of	4
inducing the production of	4
but exhibit distinct protease	4
infection by ebola and	4
in the selection of	4
in rhesus macaques infected	4
and three species of	4
blood samples were collected	4
domains of lake victoria	4
any medium or format	4
ebola vaccine in healthy	4
enveloped viruses such as	4
if material is not	4
and peripheral blood mononuclear	4
load on raw product	4
rhesus macaque model of	4
neutralizing antibody responses against	4
directly from the copyright	4
mixture of two stereoisomers	4
of hpai h n	4
filoviruses require endosomal cysteine	4
when compared to the	4
early and late endosomes	4
vector mediates postexposure protection	4
and support vector machines	4
among ehf patients in	4
this is an important	4
of emerging and re	4
of health and sanitation	4
human primates against a	4
this is consistent with	4
from ebola virus mediated	4
titers were determined by	4
ic for clomiphene was	4
resulting from direct exposure	4
in human dendritic cells	4
linked immunosorbent assay for	4
the sudv outbreak in	4
comprehensive analysis of ebola	4
structure of the envelope	4
should be addressed to	4
of the infected cell	4
and laboratory features of	4
of the congo in	4
monitored for additional days	4
was performed using the	4
authors declare no conflict	4
use is not permitted	4
and nitric oxide levels	4
vaccine vectors bypass immunity	4
the late stages of	4
with ebola virus secrete	4
that one or more	4
permission directly from the	4
analysis of the ebola	4
cells were seeded at	4
or exceeds the permitted	4
high seroprevalence of both	4
starting at or dpi	4
a systematic screen of	4
underestimation of branch lengths	4
variance log tcid ml	4
with the ifn system	4
hepatitis c virus entry	4
a preventive vaccine for	4
by a novel broad	4
the therapeutic efficacy of	4
of west nile virus	4
marburg virus disease in	4
dendritic cell stimulating activity	4
infection prevalence in exporting	4
structure of ebov gp	4
for antibodies to ebola	4
west african evd outbreak	4
give appropriate credit to	4
credit line to the	4
obtain permission directly from	4
the a u a	4
of the sars coronavirus	4
as you give appropriate	4
blood ebov turned negative	4
immunization of ebola virus	4
in the biosafety level	4
a potent inhibitor of	4
cell entry mediated by	4
the national institute for	4
protein of severe acute	4
vaccine in healthy adults	4
treatment of experimental ebola	4
mononuclear cells infected with	4
resistant to ebov infection	4
removed and cells were	4
class i fusion proteins	4
virus glycoprotein to undergo	4
cells were fixed with	4
epidemic in west africa	4
hemorrhagic fever patients and	4
monkeys with immunoglobulin from	4
protects immunocompromised nonhuman primates	4
derived human macrophages and	4
hemorrhagic fever ebola virus	4
lake victoria marburgvirus and	4
in insect cells exhibit	4
adaptation of ebola virus	4
after the second boost	4
the ns protein of	4
ebov negative reference serum	4
and ad vaccine vectors	4
in the same way	4
early stages of infection	4
sexual transmission of ebola	4
hemorrhagic fever in nonhuman	4
genetics demonstrates that proteolytic	4
primary human monocytes and	4
and rapid decline of	4
of ebola haemorrhagic fever	4
year bats may shed	4
in the endocytic pathway	4
the ebola virus matrix	4
for signs of disease	4
worst case scenario it	4
the nih aids reagent	4
using a combination of	4
to the original author	4
in vivo during infection	4
and the use of	4
of an antioxidant small	4
blocked with bovine serum	4
these results indicate that	4
acidification of the external	4
and there was no	4
the most promising candidates	4
monkeys by aerosolized ebola	4
have been implicated in	4
remdesivir reduces the time	4
of ebola viruses causing	4
phi may not be	4
virus glycoprotein counteracts bst	4
clinical virology of ebola	4
the envelope glycoprotein of	4
like mechanism and subsequent	4
gp from ebola virus	4
to the lack of	4
the use of the	4
as the main viral	4
domain of marburg virus	4
to obtain permission directly	4
humans and animals in	4
on these data the	4
replication strategies of marburg	4
gabon and republic of	4
in the induction of	4
survival and weight change	4
the use of different	4
cathepsin b l are	4
ebola virus glycoproteins on	4
manner that does not	4
the gp gene and	4
induced particle formation and	4
infected with ebov mak	4
were cloned into the	4
fusion induced by cleaved	4
within the plasma membrane	4
igg ebov negative reference	4
due to the presence	4
and replication strategies of	4
representative of three independent	4
fever in nonhuman primates	4
the zaire strain of	4
entry inhibitor for filoviruses	4
structure of ebola virus	4
binding domains of lake	4
in the design of	4
of both viruses in	4
for treatment of experimental	4
antiviral activity in vitro	4
not necessarily reflect the	4
for a role in	4
identification of the ebola	4
for compartmentalized trafficking of	4
main viral determinant of	4
vaccine design against ebov	4
this article are included	4
virus mediated by cytotoxic	4
human monocytes and macrophages	4
hemorrhagic fever in humans	4
virus glycoprotein and hiv	4
has been demonstrated in	4
marburgvirus and zaire ebolavirus	4
consider product contaminated in	4
line to the material	4
important role in the	4
unless indicated otherwise in	4
ebola virus nonstructural glycoprotein	4
it was shown that	4
log tcid ml in	4
the ebola virus nucleocapsid	4
its endosomal receptor niemann	4
molecules of the ifn	4
haemorrhagic fever ebola virus	4
and is required for	4
female balb c mice	4
new ebola virus nonstructural	4
at an early stage	4
cells exhibit dendritic cell	4
infected cynomolgus monkeys with	4
glycoprotein is not essential	4
rapid decline of central	4
posttranslational modification of nucleoprotein	4
vesicular stomatitis virus vector	4
antiviral activity of a	4
it is difficult to	4
was removed and replaced	4
postexposure protection against sudan	4
in west africa from	4
and effectiveness of an	4
virus nonstructural glycoprotein expressed	4
preventive vaccine for ebola	4
and ebolavirus cell entry	4
supernatants were harvested at	4
virus by using artificial	4
a h n virus	4
the ebola virus outbreak	4
was removed from the	4
vectors bypass immunity to	4
defective recombinant ad vaccine	4
is believed to be	4
molecular evidence of sexual	4
of sexual transmission of	4
an impact on the	4
against sudan ebola hemorrhagic	4
gp on the plasma	4
role in virus assembly	4
cathepsin b and l	4
open access article distributed	4
pubmed abstract publisher full	4
mechanism of action of	4
surface of infected cells	4
with activity against ebola	4
found that a single	4
virus nomenclature below the	4
seen in figure a	4
can be inhibited by	4
of the virus from	4
projected data have a	4
the primed ebolavirus glycoprotein	4
of the gp gene	4
environment and during transport	4
probability of introduction of	4
in domestic pigs in	4
analysis of the secreted	4
expressed through rna editing	4
for transcription and replication	4
glycoprotein gp from ebola	4
both innate and adaptive	4
primates complete protection against	4
is at present unknown	4
activated protein c for	4
have been reported in	4
mediated by cytotoxic t	4
army medical research institute	4
log normal distribution with	4
in ocular fluid during	4
in decay rates between	4
you will need to	4
macropinocytosis of zaire ebolavirus	4
the effects of clomiphene	4
cell stimulating activity and	4
counteract the antiviral factor	4
determinant of vascular cell	4
model of ebola virus	4
fresh medium was added	4
and human ebola outbreaks	4
long as you give	4
in the replication cycle	4
lower than that of	4
the resistance of mice	4
and virion glycoproteins of	4
for viral transcription and	4
target of ebov infection	4
has been used for	4
is an open access	4
outbreak resulting from direct	4
human macrophages and peripheral	4
follows a log normal	4
viruses in rousettus aegyptiacus	4
the same volume of	4
shown to be effective	4
the secondary structure of	4
and residues critical for	4
fatal and nonfatal cases	4
in a wide range	4
the development of a	4
of its body weight	4
ebola virus virulence in	4
of hemorrhagic fever virus	4
from the copyright holder	4
against infection with marburg	4
can be explained by	4
induce the expression of	4
in the live ebov	4
essential for replication in	4
in the protein data	4
cysteine proteases for entry	4
exposure treatment of ebola	4
a uniform standard error	4
fusion was independent of	4
weight over the course	4
and igm antibody findings	4
both viruses in rousettus	4
caused by the ongoing	4
like filovirus in europe	4
the images or other	4
derived dendritic cells without	4
domain c of npc	4
results of this study	4
was independent of ph	4
bypass immunity to ad	4
they have no competing	4
to confer to nonhuman	4
human ebola outbreak resulting	4
exhibit dendritic cell stimulating	4
ebola virus nucleocapsid requires	4
a log normal distribution	4
design against ebov gp	4
identification of a small	4
virus transmission events and	4
same volume of pbs	4
virus virulence in mice	4
west africa from to	4
and may result in	4
the virus from the	4
transmission events and rapid	4
a guinea pig model	4
rna editing of the	4
of lake victoria marburgvirus	4
western african evd outbreak	4
angola strain of marburg	4
randomly assigned into groups	4
against filovirus diseases by	4
for a variety of	4
is shown in fig	4
functions as a type	4
van damme et al	4
treatment was given ip	4
proteases for entry but	4
virus vector mediates postexposure	4
to a final concentration	4
survey showing cocirculation of	4
research institute of infectious	4
its body weight over	4
text free full text	4
counters the interferon system	4
results from the guinea	4
guinea pigs from lethal	4
of ebola virus glycoproteins	4
features of filoviral hemorrhagic	4
the determination of cut	4
link to the creative	4
there was evidence of	4
within the respiratory tract	4
marburg virus and three	4
with the plasma membrane	4
in the middle east	4
receptors on the surface	4
vivo during infection by	4
a complementary role to	4
hydroxyl acylation analyzed by	4
the potential of the	4
virus infection in rodents	4
viral hemorrhagic fever in	4
the surface of infected	4
in dcs and macrophages	4
a link to the	4
evidence of sexual transmission	4
demonstrates that proteolytic processing	4
prevalence of infection in	4
is often associated with	4
directed against the mutable	4
infection detected in a	4
were randomly assigned into	4
modified vaccinia virus ankara	4
essential for transcription and	4
drugs inhibiting the ebola	4
in the three areas	4
at room temperature with	4
not be a suitable	4
zaire ebolavirus bind a	4
is not included in	4
and evolution during seven	4
seroprevalence of both viruses	4
of interferon regulatory factor	4
calcium channel blocker verapamil	4
it is believed that	4
of ebola virus fusion	4
the replication cycle of	4
reston ebolavirus in humans	4
absence of any other	4
replication cycle of the	4
experimental ebola virus infections	4
of the glycoprotein gp	4
bats may shed active	4
the expression of ifn	4
antibody findings among ehf	4
of enclomiphene and zuclomiphene	4
the viral fusion world	4
model of filovirus infection	4
the equine antisera and	4
marburg and ebola virus	4
novelty in the viral	4
to minimize the risk	4
a new ebola virus	4
highlights the importance of	4
findings among ehf patients	4
endosomal cysteine proteases for	4
in liberia and sierra	4
in the resistance of	4
virus disease in johannesburg	4
in vero e and	4
in cellular cholesterol trafficking	4
detection limit of the	4
abstract publisher full text	4
not essential for replication	4
in humans and other	4
full text free full	4
potentiates the ebola virus	4
ebola virus fusion triggering	4
the ability of these	4
for detection of antibodies	4
this article is an	4
of the different ebov	4
in the viral fusion	4
efficacy and effectiveness of	4
of ebov gp by	4
into vero e cells	4
and a high seroprevalence	4
as shown in figure	4
and tongaonkar antigenicity scale	4
entry into vero e	4
from ebola virus at	4
a normal distribution of	4
fresh growth medium containing	4
based vaccine protects nonhuman	4
and incubated for h	4
reproduction in any medium	4
of host cell entry	4
with recombinant nematode anticoagulant	4
successful treatment of advanced	4
of cytokines and full	4
large serological survey showing	4
as a percentage of	4
removed and the cells	4
was observed in the	4
the cell surface is	4
high estimates of d	4
envelope glycoprotein gp from	4
inhibiting the ebola virus	4
mg kg loading dose	4
have a complementary role	4
changes were accompanied by	4
to the creative commons	4
amount of cleaved gp	4
diseases by a novel	4
ad vaccine vectors bypass	4
a role in virus	4
stomatitis virus vector mediates	4
factors that influence the	4
the initial viral load	4
prevalence in exporting country	4
the projected data have	4
protection against multistrain ebola	4
changes in gene expression	4
is known about the	4
required for inhibition of	4
the production of cytokines	4
a limited number of	4
serological survey showing cocirculation	4
and ebola virus by	4
from direct exposure to	4
of the evd patients	4
the van der waals	4
the initial concentration of	4
on endothelial cell activation	4
article is an open	4
role of the type	4
are found in the	4
dendritic cells without inducing	4
in the infected host	4
against multistrain ebola and	4
by factors such as	4
highest probability of introduction	4
in virus assembly and	4
entry of enveloped viruses	4
virus infection in a	4
glycoprotein in viral entry	4
a case of ebola	4
in the environment and	4
can be detected in	4
the mechanism by which	4
probability of at least	4
the secreted and virion	4
of the virus particles	4
for the prediction of	4
kinase axl enhances macropinocytosis	4
growth medium containing scs	4
plants and animals with	4
immune activation and increased	4
to its endosomal receptor	4
was supported by the	4
stimulating activity and induce	4
cells were cotransfected with	4
the onset of illness	4
evaluation of immune globulin	4
patients and their household	4
filovirus diseases by a	4
ebola outbreak resulting from	4
gp in viral entry	4
there is also evidence	4
declare no competing interests	4
entry but exhibit distinct	4
for host cell binding	4
samples were collected at	4
under positive selection in	4
rate of up to	4
dcs and macrophages in	4
assigned into groups of	4
using inhibitors of endocytosis	4
samples from fatal and	4
have been developed to	4
necessary for infection ebola	4
immunoglobulin from hyperimmune horses	4
uptake by a macropinocytosis	4
infection complicated by gram	4
residues critical for host	4
to ad and protect	4
bind a common receptor	4
enhances macropinocytosis of zaire	4
i interferon response in	4
virus and three species	4
with live ebov neutralisation	4
cells were cultured in	4
in accordance with the	4
nonstructural glycoprotein expressed through	4
and treatment with recombinant	4
in the viral life	4
collected in zone b	4
under the terms and	4
mice infected with ebov	4
variation in selection pressures	4
determinants of ebola virus	4
the tyro receptor kinase	4
it has also been	4
of any other data	4
of the viral membrane	4
nomenclature below the species	4
the medium was replaced	4
used in our study	4
have been identified as	4
blood samples from fatal	4
and error bars indicate	4
of the virus to	4
virus infection in primates	4
normal distribution with mean	4
negative reference serum panel	4
party material in this	4
injection vaccine protects nonhuman	4
the natural history of	4
has also been shown	4
resistance of mice to	4
the entry of the	4
patients with severe covid	4
as well as in	4
to consider product contaminated	4
analysis of human peripheral	4
marburg viruses in gabonese	4
apoptosis induced in vitro	4
article are included in	4
experimental infections of rhesus	4
igm antibody findings among	4
the site of ebov	4
the ebola virus nucleoprotein	4
prophylaxis and therapy of	4
c min log tcid	4
insights from ebola virus	4
h n highly pathogenic	4
is essential for the	4
and cd t cell	4
the innate immune response	4
to the sites of	4
glycoprotein as the main	4
as long as you	4
shedding of the glycoprotein	4
the cellular host range	4
is cleaved by the	4
reduces the time to	4
material is not included	4
absence of other information	4
it is thought that	4
and igg and igm	4
virus infection with t	4
variant of ebola virus	4
we were unable to	4
was calculated as the	4
a severe haemorrhagic fever	4
case of severe ebola	4
direct contact with bodily	4
is involved in the	4
glycoprotein to undergo a	4
of the conserved region	4
and the s protein	4
were then incubated for	4
the gps of the	4
ebola virus in ocular	4
the recent west african	4
gp pseudotyped virus neutralisation	4
virus gp in viral	4
transcription polymerase chain reaction	4
scenario it is assumed	4
of rhesus macaques with	4
second luminal domain of	4
is likely that the	4
ebola haemorrhagic fever virus	4
vascular cell cytotoxicity and	4
activation and increased vascular	4
the results of the	4
the expression of type	4
binding to ebov gp	4
experimental inoculation of plants	4
clinical and laboratory features	4
primates against lethal ebola	4
the nature of the	4
view a copy of	4
and huh cells were	4
angola infection of rhesus	4
that type i ifns	4
provide a link to	4
advanced ebola virus infection	4
other third party material	4
the low ph pulse	4
phase i clinical trials	4
is assumed that c	4
animal mortality monitoring and	4
an open access article	4
tetherin restriction in a	4
human immunodeficiency virus and	4
ebov entry into the	4
and their household contacts	4
minimum viral load to	4
a high seroprevalence of	4
single particle image analysis	4
animals in the philippines	4
infection with marburg virus	4
for ebov and marv	4
from the guinea ring	4
replication and transcription of	4
the clinical efficacy of	4
induced in vitro and	4
ebola virus glycoprotein to	4
were transferred to a	4
the highest serum dilution	4
is responsible for the	4
four fda approved drugs	4
that are required for	4
that proteolytic processing of	4
all animals were monitored	4
ml in the absence	4
was monitored for additional	4
the guinea ring vaccination	4
contact with an infected	4
a creative commons attribution	4
by the national institutes	4
the presence of vp	4
in a credit line	4
blood mononuclear cells infected	4
virus infection complicated by	4
of ebov gp that	4
fever patients and their	4
evolution during seven months	4
in wild great apes	4
results suggest that the	4
and your intended use	4
the year bats may	4
epidemic of ebola virus	4
experiment and none survived	4
and detection of neutralizing	4
the activity of cathepsins	4
visualization of ebola virus	4
directed expression of tetherin	4
lymphocytes specific for the	4
marburgvirus and ebolavirus cell	4
particle formation and association	4
molecular basis for ebola	4
wild animal mortality monitoring	4
compartmentalized trafficking of ebola	4
nonfatal cases of ebola	4
rates of up to	4
to binding in the	4
cytokine and chemokine expression	4
exposure to fruit bats	4
during infection by ebola	4
drugs for inhibitors of	4
in the eye and	4
fever ebola virus disease	4
analysis of filovirus entry	4
and disseminated intravascular coagulation	4
and indicate if changes	4
virus angola infection of	4
their ability to inhibit	4
to interfere with the	4
ebola virus glycoprotein counteracts	4
vaccine to confer to	4
given the same volume	4
with marburg virus and	4
victoria marburgvirus and zaire	4
of health and human	4
s protein of severe	4
postexposure treatment of ebola	4
trafficking of ebola and	4
images or other third	4
newborn balb c mice	4
that c min log	4
severe ebola virus infection	4
data suggest that the	4
in the ebov lifecycle	4
class i fusion protein	4
antiviral activity against ebov	4
n highly pathogenic avian	4
to fruit bats in	4
are located in the	4
favorable immune cell targeting	4
is a type i	4
during the acute phase	4
there have been a	4
cocirculation of ebola and	4
article distributed under the	4
alpha b for treatment	4
material in this article	4
a suitable surrogate for	4
basic clinical and laboratory	4
survival was monitored for	4
outbreak in south korea	4
critical for host cell	4
development of a preventive	4
cell lines were maintained	4
of the most promising	4
secreted and virion glycoproteins	4
a variety of different	4
to ebola virus disease	4
statutory regulation or exceeds	4
data have a uniform	4
protection against a lethal	4
monoclonal antibodies against ebola	4
a replication defective recombinant	4
that vp and vp	4
of type i interferon	4
molecular determinants of ebola	4
of disseminated intravascular coagulation	4
not require tetherin surface	4
ebola hemorrhagic fever patients	4
mortality monitoring and human	4
the ebov outbreak in	4
supernatant was removed and	4
the threat posed by	4
or in combination with	4
virus matrix protein vp	4
and in vivo during	4
of pseudotyped virus input	4
access article distributed under	4
strategies of marburg virus	4
susceptible to infection by	4
the sites of budding	4
by using artificial replication	4
case scenario it is	4
our results suggest that	4
extent of fusion was	4
in any medium or	4
a function of time	4
there was no significant	4
patients with confirmed evd	4
in the african straw	4
require tetherin surface removal	4
the glycoprotein of marburg	4
distributed under the terms	4
mediates postexposure protection against	4
seven months in sierra	4
ebolavirus bind a common	4
against lethal challenge in	4
been found to be	4
the nucleoprotein of ebola	4
approved drugs for inhibitors	4
inoculation of plants and	4
department of health and	4
appropriate credit to the	4
with an infected person	4
protection against sudan ebola	4
and incorporation into virions	4
glycoproteins on endothelial cell	4
terms and conditions of	4
little is known about	4
peptide immunoadhesins inhibit marburgvirus	4
characterization of host immune	4
for a wide range	4
binding of gp to	4
entry into host cells	4
ready form of the	4
mice to filovirus infection	4
bound to its endosomal	4
the incubation period of	4
doses as low as	4
and marburg viruses replicate	4
virus nucleocapsid requires virion	4
the role of type	4
marburg virus and the	4
a nonhuman primate model	4
a credit line to	4
gateway for compartmentalized trafficking	4
entry into the host	4
fever in humans and	4
virus glycoproteins on endothelial	4
indicate if changes were	4
passive immunization of ebola	4
and animals in the	4
human peripheral blood samples	4
paucity of information regarding	4
igg and igm antibody	4
patients treated with remdesivir	4
these data indicate that	4
a novelty in the	4
these findings suggest that	4
that they are modified	4
in this article are	4
confer to nonhuman primates	4
with immunoglobulin from hyperimmune	4
medical research institute of	4
from the plasma membrane	4
the cells were transfected	4
lethal experimental infections of	4
product contaminated in eu	4
basis for ebola virus	4
the glycoprotein gp of	4
b for treatment of	4
bat infection prevalence in	4
l are not required	4
when the drug was	4
proteins and and posttranslational	4
in the management of	4
these data suggest that	4
mouse model of ebola	4
by the fact that	4
amino acid change in	4
t lymphocytes specific for	4
and association with the	4
associated proteins and and	4
the environment and during	4
for entry but exhibit	4
of a preventive vaccine	4
the development of antiviral	4